Bluemount Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Bluemount Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anwar Andikadan and Anil Sundaresan serve as directors at the Company.
- CIN/LLPIN
U24239TZ2015PTC022000
- Company No.
022000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Nilgiris, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bluemount Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sundaresan  | Director | 22-Aug-2022 | Current |
| Anwar Andikadan | Director | 23-Nov-2015 | Current |
Financial Performance of Bluemount Pharmaceutical.
Enhance accessibility to Bluemount Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bluemount Pharmaceutical?
Unlock access to Bluemount Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bluemount Clinic Mysore Private LimitedActive 1 year 3 monthsAnwar Andikadan and Anil Sundaresan are mutual person
- Nilgiri Institute Of Medical Sciences LimitedActive 13 years 7 months
Anwar Andikadan and Anil Sundaresan are mutual person
- Thanusugam Private LimitedActive 2 months 1 day
Anwar Andikadan and Anil Sundaresan are mutual person
- Green Hills Educational And Charitable InstitutionsActive 12 years 2 months
Anil Sundaresan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bluemount Pharmaceutical?
Unlock and access historical data on people associated with Bluemount Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bluemount Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bluemount Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
